Archie Bleyer, MD

Clinical Research Professor, Radiation Medicine

Archie Bleyer, M.D.

Archie Bleyer, MD, is Chair of the Institutional Research Board, Cascade Healthcare Community; Director of Aflac/CureSearch Adolescent and Young Adult Cancer Research; and founding member of the LiveStrong Young Adult Alliance.  

Dr. Bleyer chaired the Children’s Cancer Group for 10 years, then the world's largest pediatric cancer research organization, the Department and Division of Pediatrics at the University of Texas MD Anderson Cancer Center, and Community Oncology in the Department and Division of Medicine at the M.D. Anderson Cancer Center. He was the American Cancer Society Professor of Clinical Oncology and in charge of the cancer curriculum in the University of Washington School of Medicine. During the past three decades, 

Dr. Bleyer was awarded research grants totaling more than $75 million as a principal investigator from the National Institutes of Health, the American Cancer Society, and the Leukemia Society of America. His research has been published in more than 300 peer-reviewed articles, chapters, and books.His current personal clinical research is dedicated to adolescents and young adult (AYA) oncology.

Education

Undergraduate:

     Massachusetts Institute of Technology

Medical Education:

    University of Rochester, School of Medicine and Dentistry 

Residency Training:

     Pediatric Medicine, University of Washington, School of Medicine

Fellowship:

     National Cancer Institute 

     University of Washington, School of Medicine

Selected Publications

Pediatr Blood Cancer. 2018 Jul;65(7):e27013. doi: 10.1002/pbc.27013. Epub 2018 Mar 1. The challenge of the management of adolescents and young adults with soft tissue sarcomas. Ferrari A, Bleyer A, Patel S, Chiaravalli S, Gasparini P, Casanova M. https://www.ncbi.nlm.nih.gov/pubmed/29493075
Pediatr Blood Cancer. 2018 Aug;65(8):e27025. doi: 10.1002/pbc.27025. Epub 2018 Mar 12. Thyroid cancer in adolescents and young adults. Massimino M, Evans DB, Podda M, Spinelli C, Collini P, Pizzi N, Bleyer A. https://www.ncbi.nlm.nih.gov/pubmed/29528191

Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection – a review.  Beaupin L, Bostrom B, Barth M, Jaeger R, Kamath P, Schreiber B, Bleyer A. Pages 766-772 | Received 01 Feb 2016, Accepted 24 Jul 2016, Published online: 19 Sep 2016

Future Oncology VOL. 13, NO. 14 | Special Report. Thyroid cancer in adolescents and young adults. 15 Jun 2017 Doi: https://doi.org/10.2217/fon-2017-0024     

Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27. Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. Ramsey LB, Balis FM, O'Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A,Schwartz S, Vinks AA, Heldrup J.

Could the Rising Rates of Colorectal Cancer in AYAs Be Linked to HPV Infection?

Into the Age of Miracles & the Greatest Story Ever Told

Generalizability of SWOG Treatment Trial Results

Were Our Estimates of Over diagnosis With Mammography Screening in the United States "Based on Faulty Science"?

"Cancer in Adolescents & Young Adults (AYA): Epidemiology, Mortality, Survival, USA" - Institute of Medicine, Policy Implications, July 2013, Dr. WA Bleyer

Dr. Bleyer is sr. author on major SEER database update on breast cancer incidence patters

Young Adults, Cancer, Health Insurance, Socioeconomic Status, and the Patient Protection and Affordable Care Act

Dr. Bleyer is co-author of a population-based research analysis

New York Time: "In Cancer Fight, Teenagers Don't Fit In"

ASCO 2009 poster, "Turnaround in Adolescent and Young Adult (AYA) Cancer Treatment Trial Activity and Early Evidence for Reduction in National Mortality in the United States"

Presentation flyer: "Advances in Treatment Options for Adolescent Young Adult Population" (June, 2010)  

Increased Vulnerability of the Spinal Cord to Radiation or Intrathecal Chemotherapy During Adolescence: A Report From the Children's Oncology Group  

Relative Lack of Conditional Survival Improvement in Young Adults With Cancer 

Young Adults, Cancer, Health Insurance, Socioeconomic Status, and the Patient Protection. and Affordable Care Act